Hospira METRONIDazole IV Injection Recall: Leaking Bags Risk Contamination
Hospira recalls 500mg METRONIDazole IV injections with leaking bags that may cause contamination. Stop using if leaking.
Use caution until it’s fixed
Lack of Sterility Assurance: customer report of leaking bag
Contact the company
What happened, in plain English
Hospira is recalling METRONIDazole injection vials that may leak, risking contamination during IV use. This affects healthcare providers using the product for medical treatments. Read more at govinfonow.com/recall/41991-hospira-metronidazole-iv-injection-recall-leaking-bags-risk-contamination.
Source Summary by GovInfoNow · govinfonow.com/recall/41991-hospira-metronidazole-iv-injection-recall-leaking-bags-risk-contamination · Updated October 8, 2026 · FDA enforcement record: FDA #D-0480-2017
Cite this page
“Hospira METRONIDazole IV Injection Recall: Leaking Bags Risk Contamination.” GovInfoNow, updated October 8, 2026. https://govinfonow.com/recall/41991-hospira-metronidazole-iv-injection-recall-leaking-bags-risk-contamination. Based on FDA recall #D-0480-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0480-2017%22&limit=1).
Why it’s dangerous
The injection vials may leak, which can lead to contamination of the medication. This poses a risk of infection or improper treatment if the leaking vial is used during IV administration.
Who’s affected
Healthcare providers using the recalled METRONIDazole injection for IV treatments. Patients receiving the medication are at risk if the leak occurs during administration.
How to tell if you have this one
Check for vials labeled METRONIDazole Injection, USP 500 mg (5 mg/mL) in 100 mL Single Dose Flexible Container. The NDC code is 0409-7811-24 with lot number 54-054-JT from June 1, 2017.
- Brand
Hospira- Category
Drug
What to do — step by step
Check for Leaks
Inspect the vial for signs of leakage, as leaking bags may cause contamination during IV use.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2.1 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0480-2017 (February 10, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0480-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 8, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.